MENU
+Compare
BBC
ETF ticker: NYSE ARCA
AS OF
Jul 3 closing price
Price
$20.32
Change
+$0.13 (+0.64%)
Net Assets
11.18M

BBC stock forecast, quote, news & analysis

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index... Show more

Category: #Health
BBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BBC with price predictions
Jul 03, 2025

Momentum Indicator for BBC turns positive, indicating new upward trend

BBC saw its Momentum Indicator move above the 0 level on July 02, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

BBC moved above its 50-day moving average on May 28, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBC advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 161 cases where BBC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BBC moved out of overbought territory on June 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for BBC turned negative on June 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BBC broke above its upper Bollinger Band on July 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Arrowhead Pharmaceuticals (NASDAQ:ARWR).

Industry description

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Market Cap

The average market capitalization across the Virtus LifeSci Biotech Clinical Trls ETF ETF is 1.32B. The market cap for tickers in the group ranges from 77.35M to 18.23B. SMMT holds the highest valuation in this group at 18.23B. The lowest valued company is PLRX at 77.35M.

High and low price notable news

The average weekly price growth across all stocks in the Virtus LifeSci Biotech Clinical Trls ETF ETF was 3%. For the same ETF, the average monthly price growth was 3%, and the average quarterly price growth was -18%. ALT experienced the highest price growth at 32%, while DYN experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Virtus LifeSci Biotech Clinical Trls ETF ETF was -51%. For the same stocks of the ETF, the average monthly volume growth was -59% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 82
Price Growth Rating: 56
SMR Rating: 93
Profit Risk Rating: 93
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
BBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
501 Madison Avenue, Suite 501New YorkNew York
Phone
(212) 593-4383
Web
N/A